Clinical Feature: Getting to the heart of itHow pharmacists can improve adherence in patients with cardiovascular disease. New research finds pharmacist prescribing significantly reduces hypertensionEvidence from RxACTION study shows it is time to move from research to implementation, says Ross Tsuyuki. Trial trumpets LDL lowering Does sitagliptin increase cardiovascular risk in diabetes patients? New study shows no apparent increased risk of major adverse cardiovascular events or hospitalization for heart failure. Inaugural Peter Munk Chair in structural heart disease intervention announced Device treats heart failure via the spinal cord Technique has produced mixed results in trials Manitoba Health says pediatric cardiac care program not likely to be revived New simplified lipid pathway for reducing cardiovascular risk in primary care Alberta TOP clinical practice guideline streamlines statin prescribing and reduces lipid monitoring. Case Report: Dealing with dyslipidemia through positive dietary change Migraine is a cardiovascular risk factor Meta-analysis links the headaches with MI and angina First Previous 39 40 41 42 43 Next Last